Captor Therapeutics received funding for a new R&D project to develop innovative therapeutics and investigate novel drug candidates.
"Inducing apoptosis with small molecules as therapeutic intervention in multiple severe malignancies" co-financed by European Regional Development Fund through POIR program for years 2014-2020 NCBR, measure 1.1 "R&D projects of enterprises", sub-measure 1.1.1 "Industrial research and development work implemented by enterprises". Project number: POIR.01.01.01-00-0956/17
Share:
